The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.EBI
Northwestern University
Potent inhibitors of Huntingtin protein aggregation in a cell-based assay.EBI
Columbia University
Nucleic-Acid-Based Targeted Degradation in Drug Discovery.EBI
Second Military Medical University
Novel Substituted Heteroaryl Compounds for Treating Huntington's Disease.EBI
Smith, Gambrell & Russell
 
Synthesis and pharmacological evaluation of 4-[2- hydroxy-3-(4-phenyl-piperazin-1-yl)-propoxy]-4- azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dioneBDB
The Medical University of Warsaw